- Home
- MTX vs OLMA Comparison
MTX vs OLMA Comparison
Compare MTX & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTX | OLMA |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1992 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MTX | OLMA |
|---|---|---|
| Price | $67.59 | $27.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $79.67 | $41.14 |
| AVG Volume (30 Days) | 167.2K | ★ 1.5M |
| Earning Date | 01-29-2026 | 11-10-2025 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,071,200,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $49.54 | $2.86 |
| 52 Week High | $78.23 | $36.26 |
Technical Indicators
Market Signals| Indicator | MTX | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 72.08 | 51.64 |
| Support Level | $65.82 | $26.93 |
| Resistance Level | $68.24 | $29.47 |
| Average True Range (ATR) | 1.59 | 1.59 |
| MACD | 0.40 | -0.13 |
| Stochastic Oscillator | 87.42 | 58.43 |
Price Performance
Historical ComparisonAbout MTX Minerals Technologies Inc.
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products. The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.